Literature DB >> 21873235

Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines.

Stephan Hailfinger1, Hendrik Nogai, Christiane Pelzer, Maike Jaworski, Katrin Cabalzar, Jean-Enno Charton, Montserrat Guzzardi, Chantal Décaillet, Michael Grau, Bernd Dörken, Peter Lenz, Georg Lenz, Margot Thome.   

Abstract

The protease activity of the paracaspase Malt1 contributes to antigen receptor-mediated lymphocyte activation and lymphomagenesis. Malt1 activity is required for optimal NF-κB activation, but little is known about the responsible substrate(s). Here we report that Malt1 cleaved the NF-κB family member RelB after Arg-85. RelB cleavage induced its proteasomal degradation and specifically controlled DNA binding of RelA- or c-Rel-containing NF-κB complexes. Overexpression of RelB inhibited expression of canonical NF-κB target genes and led to impaired survival of diffuse large B-cell lymphoma cell lines characterized by constitutive Malt1 activity. These findings identify a central role for Malt1-dependent RelB cleavage in canonical NF-κB activation and thereby provide a rationale for the targeting of Malt1 in immunomodulation and cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21873235      PMCID: PMC3167514          DOI: 10.1073/pnas.1105020108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20.

Authors:  Beatrice Coornaert; Mathijs Baens; Karen Heyninck; Tine Bekaert; Mira Haegman; Jens Staal; Lijun Sun; Zhijian J Chen; Peter Marynen; Rudi Beyaert
Journal:  Nat Immunol       Date:  2008-01-27       Impact factor: 25.606

Review 2.  Antigen-receptor signaling to nuclear factor kappa B.

Authors:  Jan Schulze-Luehrmann; Sankar Ghosh
Journal:  Immunity       Date:  2006-11       Impact factor: 31.745

3.  Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells.

Authors:  Uta Ferch; Bernhard Kloo; Andreas Gewies; Vera Pfänder; Michael Düwel; Christian Peschel; Daniel Krappmann; Jürgen Ruland
Journal:  J Exp Med       Date:  2009-10-19       Impact factor: 14.307

4.  A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.

Authors:  Michael Düwel; Verena Welteke; Andrea Oeckinghaus; Mathijs Baens; Bernhard Kloo; Uta Ferch; Bryant G Darnay; Jürgen Ruland; Peter Marynen; Daniel Krappmann
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

Review 5.  New regulators of NF-kappaB in inflammation.

Authors:  Sankar Ghosh; Matthew S Hayden
Journal:  Nat Rev Immunol       Date:  2008-11       Impact factor: 53.106

Review 6.  Multifunctional roles for MALT1 in T-cell activation.

Authors:  Margot Thome
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

7.  Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma.

Authors:  Stephan Hailfinger; Georg Lenz; Vu Ngo; Anita Posvitz-Fejfar; Fabien Rebeaud; Montserrat Guzzardi; Eva-Maria Murga Penas; Judith Dierlamm; Wing C Chan; Louis M Staudt; Margot Thome
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-06       Impact factor: 11.205

8.  The aryl hydrocarbon nuclear translocator alters CD30-mediated NF-kappaB-dependent transcription.

Authors:  Casey W Wright; Colin S Duckett
Journal:  Science       Date:  2009-01-09       Impact factor: 47.728

Review 9.  Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls.

Authors:  Véronique Baud; Michael Karin
Journal:  Nat Rev Drug Discov       Date:  2009-01       Impact factor: 84.694

Review 10.  Regulation and function of NF-kappaB transcription factors in the immune system.

Authors:  Sivakumar Vallabhapurapu; Michael Karin
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

View more
  92 in total

1.  Mechanism and specificity of the human paracaspase MALT1.

Authors:  Janna Hachmann; Scott J Snipas; Bram J van Raam; Erik M Cancino; Emily J Houlihan; Marcin Poreba; Paulina Kasperkiewicz; Marcin Drag; Guy S Salvesen
Journal:  Biochem J       Date:  2012-04-01       Impact factor: 3.857

2.  Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity.

Authors:  Maike Jaworski; Ben J Marsland; Jasmine Gehrig; Werner Held; Stéphanie Favre; Sanjiv A Luther; Mai Perroud; Déla Golshayan; Olivier Gaide; Margot Thome
Journal:  EMBO J       Date:  2014-10-15       Impact factor: 11.598

3.  MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types.

Authors:  Peter C Lucas; Linda M McAllister-Lucas; J Randall McAuley; Kelly M Bailey; Prasanna Ekambaram; Linda R Klei; Heejae Kang; Dong Hu; Tanner J Freeman; Vincent J Concel; Nathaniel E Hubel; Jia-Ying Lloyd Lee; Hanna B Klei; Jing Cheng; Preethiya Sekar; Rachel E Bridwell; Lidija Covic
Journal:  Oncogene       Date:  2019-08-16       Impact factor: 9.867

Review 4.  Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.

Authors:  Rosalba Camicia; Hans C Winkler; Paul O Hassa
Journal:  Mol Cancer       Date:  2015-12-11       Impact factor: 27.401

5.  IKK phosphorylates RelB to modulate its promoter specificity and promote fibroblast migration downstream of TNF receptors.

Authors:  Hélène Authier; Katy Billot; Emmanuel Derudder; Didier Bordereaux; Pierre Rivière; Sylvie Rodrigues-Ferreira; Clara Nahmias; Véronique Baud
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

Review 6.  Metacaspases versus caspases in development and cell fate regulation.

Authors:  E A Minina; N S Coll; H Tuominen; P V Bozhkov
Journal:  Cell Death Differ       Date:  2017-02-24       Impact factor: 15.828

7.  Carbon dioxide-dependent regulation of NF-κB family members RelB and p100 gives molecular insight into CO2-dependent immune regulation.

Authors:  Ciara E Keogh; Carsten C Scholz; Javier Rodriguez; Andrew C Selfridge; Alexander von Kriegsheim; Eoin P Cummins
Journal:  J Biol Chem       Date:  2017-05-15       Impact factor: 5.157

8.  MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo.

Authors:  Lorena Fontan; Chenghua Yang; Venkataraman Kabaleeswaran; Laurent Volpon; Michael J Osborne; Elena Beltran; Monica Garcia; Leandro Cerchietti; Rita Shaknovich; Shao Ning Yang; Fang Fang; Randy D Gascoyne; Jose Angel Martinez-Climent; J Fraser Glickman; Katherine Borden; Hao Wu; Ari Melnick
Journal:  Cancer Cell       Date:  2012-12-11       Impact factor: 31.743

Review 9.  The Paracaspase MALT1.

Authors:  Janna Hachmann; Guy S Salvesen
Journal:  Biochimie       Date:  2015-09-16       Impact factor: 4.079

Review 10.  Targeting pathological B cell receptor signalling in lymphoid malignancies.

Authors:  Ryan M Young; Louis M Staudt
Journal:  Nat Rev Drug Discov       Date:  2013-03       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.